Regencell Bioscience Holdings Ltd (RGC): Shares Outstanding

Annual figures by period end, from SEC filings.

Figures left out. The filed Shares Outstanding for the year ended 2026-06-30 is not shown: shares outstanding out of scale with net income per share. That usually means the filing tagged the figure in the wrong unit.

494.49M
As of 2025-06-30
+236.2%
3-year compound annual growth
+118.2%
5-year compound annual growth
2020-06-30: 10.00M2021-06-30: 10.00M2022-06-30: 13.01M2023-06-30: 13.01M2024-06-30: 13.01M2025-06-30: 494.49M494.49M
2020-06-30 Shares Outstanding (shares) 2025-06-30
Period endedShares OutstandingChange YoYSource filing
2025-06-30494.49Mn/m2026-10-07, Balance as of period end
2024-06-3013.01M0.0%2024-10-25, Balance as of period end
2023-06-3013.01M0.0%2024-10-25, Balance as of period end
2022-06-3013.01M+30.1%2023-10-27, Balance as of period end
2021-06-3010.00M0.0%2022-10-31, Balance as of period end
2020-06-3010.00Mn/a2021-10-29, Balance as of period end